Stock UniverseDerived research view · source repositories remain read-only

eXoZymes, Inc. (EXOZ)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
20.09
Global Rank
3350
Market Cap
74.34M
Latest Close
9.34
RS Composite
-13.16% · G#2287

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-11.39%
3M
27.72%
6M
-37.73%
1Y
-31.32%
3Y
7.98%
5Y
7.98%
10Y
7.98%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 4.63K · 30-day average: 3.59K · Max drawdown over stored range: -65.45%

Research Snapshot

Relative Strength vs SPX

RS Composite-13.16%
20D RS-7.24%
60D RS18.97%
120D RS-48.25%
Global RS Rank2287 · 31.83% percentile
Watch+Speculative RS Rank1421 · 32.24% percentile
Group ScopeWatch+Speculative
Primary RS Rank236 · 48.47% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank458 / 701
Primary Percentile34.81
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for EXOZ.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue00.02860.07010
Revenue Growth (YoY)2400%2400%145.014%2400%
Gross Profit00.02860.07010
Operating Income-1.2928-1.3327-1.7962-5.9321
Free Cash Flow-2.0093-1.4431-1.4696-8.9021-6.672
Free Cash Flow Per Share-0.388-0.242-0.235-1.356-0.796039
EPS (Diluted) GAAP-0.233255-0.233918-0.326142-0.893053
EPS Growth
EPS Non-GAAP
Gross Margin2400%100%100%2400%
Operating Margin2400%-4660.001%-2563.505%2400%
Profit Margin2400%-4881.908%-2909.117%2400%
Free Cash Flow Margin2400%-5046.084%-2097.335%2400%
Shares Outstanding (Diluted)5.18365.96846.256.56338.3814
Shares Change (YoY)2400%15.14%4.718%5.012%27.702%

SEC Quarterly Fundamentals

No processed quarterly rows for EXOZ.